TRANSPHORM INC's ticker is TGAN and the CUSIP is 89386L100. A total of 40 filers reported holding TRANSPHORM INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $186,962 | -25.1% | 84,217 | +14.8% | 0.00% | – |
| Q2 2023 | $249,512 | +1.2% | 73,386 | +18.7% | 0.00% | – |
| Q1 2023 | $246,610 | -26.7% | 61,807 | 0.0% | 0.00% | – |
| Q4 2022 | $336,230 | +8.1% | 61,807 | +0.1% | 0.00% | – |
| Q3 2022 | $311,000 | +72.8% | 61,730 | +31.0% | 0.00% | – |
| Q2 2022 | $180,000 | – | 47,114 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 3,609,346 | $14,401,291 | 5.31% |
| Kohlberg Kravis Roberts & Co. L.P. | 22,675,980 | $90,477,160 | 2.72% |
| Worth Venture Partners, LLC | 884,802 | $3,530,360 | 1.72% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 253,084 | $1,009,805 | 1.18% |
| Black Maple Capital Management LP | 43,161 | $172,212 | 0.16% |
| Polar Asset Management Partners Inc. | 709,700 | $2,831,703 | 0.04% |
| Soros Fund Management | 639,820 | $2,552,882 | 0.04% |
| AMERIPRISE FINANCIAL INC | 3,929,048 | $15,676,901 | 0.01% |
| Stratos Wealth Partners, LTD. | 25,640 | $102,304 | 0.00% |
| FMR LLC | 1,584 | $6,320 | 0.00% |